NASDAQ: CRSPCrispr Therapeutics Ag Stock Ownership - Who owns Crispr Therapeutics Ag?
Insider buying vs selling
Have Crispr Therapeutics Ag insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Samarth Kulkarni | Chief Executive Officer | 2025-08-18 | 13,081 | $58.15 | $760.66kSell |
| Douglas A. Treco | Director | 2025-08-06 | 20,000 | $57.03 | $1.14MBuy |
| Simeon George | Director | 2025-07-16 | 960,983 | $52.03 | $50.00MBuy |
| Simeon George | Director | 2025-07-16 | 6,510 | $52.03 | $338.72kBuy |
| Simeon George | Director | 2025-07-16 | 22,319 | $52.03 | $1.16MBuy |
| Naimish Patel | Chief Medical Officer | 2025-05-29 | 3,932 | $35.94 | $141.32kSell |
| Samarth Kulkarni | Chief Executive Officer | 2025-03-21 | 10,031 | $41.23 | $413.58kSell |
| Julianne Bruno | Chief Operating Officer | 2025-03-21 | 1,714 | $41.23 | $70.67kSell |
| Raju Prasad | Chief Financial Officer | 2025-03-21 | 2,197 | $41.23 | $90.58kSell |
| James R. Kasinger | General Counsel and Secretary | 2025-03-21 | 3,185 | $41.23 | $131.32kSell |
CRSP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CRSP insiders and whales buy or sell their stock.
CRSP Shareholders
What type of owners hold Crispr Therapeutics Ag stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ark Investment Management LLC | 11.20% | 10,182,590 | $572.87M | Institution |
| Celgene Corp | 9.41% | 8,557,514 | $481.45M | Insider |
| Blackrock Inc | 6.67% | 6,066,358 | $341.29M | Institution |
| Capital International Investors | 6.15% | 5,593,747 | $314.70M | Institution |
| Vertex Pharmaceuticals Europe Ltd | 5.92% | 5,380,940 | $302.73M | Insider |
| Simeon George | 5.78% | 5,259,390 | $295.89M | Insider |
| Bayer Global Investments Bv | 5.61% | 5,105,330 | $287.23M | Insider |
| T Rowe Price Investment Management Inc | 4.05% | 3,683,026 | $207.21M | Institution |
| State Street Corp | 3.60% | 3,270,596 | $184.00M | Institution |
| Glaxosmithkline PLC | 3.54% | 3,220,627 | $181.19M | Insider |
CRSP vs Biotech Stocks
Crispr Therapeutics Ag Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.